Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 25%
Hold 50%
Sell 13%
Strong Sell 0%

Bulls say

National Health Investors Inc. is projected to experience significant financial growth, with expectations of 2.2% year-over-year normalized Funds From Operations per share (FFOps) growth in 2024, escalating to 5.0% in 2025. The company is anticipated to achieve an average annual normalized FFOps growth rate of 4.1% from 2024 to 2029, driven by improving fundamentals and enhanced operator performance. Additionally, the potential growth of the Senior Housing Operating Portfolio, currently at 4.5% of the overall portfolio, to 30% within five years, coupled with favorable lease negotiations, suggests a positive trajectory for shareholder value in the coming years.

Bears say

National Health Investors Inc has experienced an 18% decline in stock value over the past three months, outpacing the VNQ's 10% decline, while also trading at a premium relative to its historical averages. The company faces challenges with lower expected earnings growth due to difficulties with operators, such as Discovery, which has underperformed against cash flow projections, and potential unfavorable rent restructurings as the sector recovers from the pandemic. Additionally, a revision of the 2025 Funds from Operations (FFO) estimate indicates declining performance expectations, with estimated occupancy rates for the Senior Housing Operating Portfolio remaining below targets, further contributing to a cautious outlook on the stock.

NHI has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Hold based on their latest research and market trends.

According to 16 analysts, NHI has a Hold consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $69.19, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $69.19, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.